This study was conducted from the strategic marketing perspective to test the impact of brand relationship types on brand loyalty. We also test three path effects of brand love and brand trust. Data were collected from three metropolitan customers who use tablet PCs. We obtained 383 valid samples, giving a valid response rate of 89%. Data analysis was performed with SmartPLS2.0 and SPSS 23.0 to test the proposed model. The results indicate that an expressive brand relationship significantly predicts brand trust and brand loyalty. In turn, brand trust has a positive influence on brand love, while brand awareness and brand love influence attitudinal and behavioral loyalty. Expressive brand relationship has two indirect mediating affects via brand trust and brand love, which influence brand loyalty. Finally, we suggest managerial implications and directions for future research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067968 | PMC |
http://dx.doi.org/10.3389/fpsyg.2020.00231 | DOI Listing |
Cureus
August 2024
Pathology, All India Institute of Medical Sciences (AIIMS), Madurai, IND.
In the urban landscape of Chennai, a pathologist, deeply concerned about the future of the younger generation, initiated a community-driven initiative aimed at fostering physical and mental wellness among children. Through a blend of captivating storytelling and stimulating puzzle sessions, the initiative sought to combat trends of laziness, gadget dependency, and poor dietary habits prevalent among youth. The sessions, designed to engage young minds while imparting valuable life lessons and problem-solving skills, garnered remarkable responses from participants and parents alike.
View Article and Find Full Text PDFClin Lung Cancer
December 2024
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Respiratory Medicine, Alfred Health, Melbourne, Australia.
Background: Lung cancer in Australia contributes 9% of all new cancer diagnoses and is the leading cause of cancer death and burden. Clinical practice guidelines provide evidence-based treatment recommendations for best practice management. We aimed to determine the extent of delivery of guideline-concordant treatment (GCT) and to identify modifiable variables influencing receipt of GCT and survival.
View Article and Find Full Text PDFJ R Stat Soc Series B Stat Methodol
September 2024
Department of Radiology, University of Washington, Seattle, USA.
We introduce a novel framework for the classification of functional data supported on nonlinear, and possibly random, manifold domains. The motivating application is the identification of subjects with Alzheimer's disease from their cortical surface geometry and associated cortical thickness map. The proposed model is based upon a reformulation of the classification problem as a regularized multivariate functional linear regression model.
View Article and Find Full Text PDFMol Cancer
August 2024
The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
PARP inhibitor (PARPi) therapy has transformed outcomes for patients with homologous recombination DNA repair (HRR) deficient ovarian cancers, for example those with BRCA1 or BRCA2 gene defects. Unfortunately, PARPi resistance is common. Multiple resistance mechanisms have been described, including secondary mutations that restore the HR gene reading frame.
View Article and Find Full Text PDFJAMA Neurol
October 2024
Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Importance: The lack of an in vivo measure for α-synuclein (α-syn) pathology until recently has limited thorough characterization of its brain atrophy pattern, especially during early disease stages.
Objective: To assess the association of state-of-the-art cerebrospinal fluid (CSF) seed amplification assays (SAA) α-syn positivity (SAA α-syn+) with magnetic resonance imaging (MRI) structural measures, across the continuum from clinically unimpaired (CU) to cognitively impaired (CI) individuals, in 3 independent cohorts, and separately in CU and CI individuals, the latter reflecting a memory clinic population.
Design, Setting, And Participants: Cross-sectional data were used from the Swedish BioFINDER-2 study (inclusion, 2017-2023) as the discovery cohort and the Swedish BioFINDER-1 study (inclusion, 2007-2015) and Alzheimer's Disease Neuroimaging Initiative (ADNI; inclusion 2005-2022) as replication cohorts.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!